MarketLens
Sign Up

What Do Plus Therapeutics' Latest Financials Tell Us

4 months ago
SHARE THIS ON:

What Do Plus Therapeutics' Latest Financials Tell Us

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major Catalyst

Helus Pharma's psychedelic platform, spanning MDD and GAD, approaches a phase III catalyst for HLP003. Early data suggest efficacy, but small trials limit validation. Positive results could reduce its...
Stock News•2 months ago

Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics' CNSide CSF assay coverage rose to ~127M people after a regional agreement with Medical Mutual covering 1.2M in Ohio and Kentucky, effective July 1.
Stock News•2 months ago

What This PTC Therapeutics Insider Sale Means as Product Revenue Hit $226 Million

PTC Therapeutics product revenue reached $226M, while an insider sold shares at ~$90.25, generating $222K from option exercises. The sale represented 4% of the insider's direct holdings.

Breaking News

View All →

Top Headlines

View More →
Stock News•47 minutes ago

New Mexico wants Meta to pay up to $40 billion in penalties after data privacy trial

Stock News•1 hour ago

Pilots of crashed Amazon cargo plane were unaware of wind conditions

Stock News•1 hour ago

Alphabet (GOOGL) Stock Sinks As Market Gains: What You Should Know

Stock News•1 hour ago

Micron Isn't Stepping Off The Gas

Stock News•2 hours ago

Buy Micron Stock After AI Memory Demand Fuels Record Q4 Results?